![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and British Society of Gastroenterology International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8â9 June 2019 - ()] Clinical Hepatology - IDDF2019-ABS-0133â Routinely available noninvasive tests discriminate advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib
Wong, Vincent Wai-Sun, Anstee, Quentin, Lawitz, Eric, Alkhouri, Naim, Romero-Gomez, Manuel, Okanoue, Takeshi, Trauner, Michael, Kersey, Kathryn, Li, Georgia, Subramanian, Mani, Myers, Robert, Djedjos,Year:
2019
DOI:
10.1136/gutjnl-2019-iddfabstracts.267
File:
PDF, 56 KB
2019